Firm News

Feldesman Managing Partner Ted Waters will speak at Community Action Program Legal Services (CAPLAW)’s 2025 National Training Conference, taking place May 28 - 30 in Boston, MA. His session, “Ted Talk(s): Federal [...]

On Monday, May 19, the U.S. Department of Justice issued a memorandum announcing the launch of a new “Civil Rights Fraud Initiative,” aimed at investigating and pursuing claims under the False Claims [...]

Feldesman Partners Phillip Escoriaza and Ted Waters will speak at the National Head Start Association’s (NHSA) 2025 Conference, taking place from May 19 – 22, 2025, in Columbus, Ohio. Their sessions will [...]

Feldesman Partners Mindy Pava and Ted Waters will present a webinar as part of the 2025 Changing Federal Landscape Community, an initiative of the National Council of University Research Administrators (NCURA). Scheduled [...]

Key Challenges Still Loom for Covered Entities On Monday, May 12, the White House issued an Executive Order (EO) aimed at addressing  prescription drug prices. The EO opens with a remarkable [...]

Feldesman Leifer LLP is excited to announce that Partners Kathryn E. Doi, Ted Waters, Adam J. Falcone, and Gabriel S. García will present multiple sessions at the California Primary Care Association’s (CPCA) [...]

Feldesman Managing Partner Ted Waters  will share insights on the latest legal and compliance developments affecting federal grant management during a webinar hosted by the National Grants Management Association. Drawing on decades [...]

Feldesman Partner Mindy Pava will present at the Virtual Research Administration Conference hosted by the Society of Research Administrators International (SRAI), from April 23 – 25, 2025.  This year’s conference will explore [...]

Feldesman Managing Partner Ted Waters will present “Grants Management, Risk Mitigation, and Practical Responses to an Evolving Federal Landscape” at the Community Health Care Association of New York State’s (CHCANYS) annual Finance [...]

On April 15, President Trump signed an Executive Order reviving a previous directive to reduce the cost of insulin and injectable epinephrine for low income individuals. The Executive Order instructs the Secretary [...]